
Biodesix BDSX
€ 13.24
4.56%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Biodesix EV 2011-2026 | BDSX
EV Jährlich Biodesix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 M | 200 M | 102 M | 168 M | 115 M | 265 M | 237 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 265 M | 102 M | 176 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
1.01 B | $ 9.2 | 2.17 % | $ 613 M | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.14 | 0.47 % | $ 4.92 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 16.25 | -0.49 % | $ 491 M | ||
|
Guardant Health
GH
|
15.2 B | $ 83.44 | -1.79 % | $ 10.5 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 102.22 | 1.86 % | $ 8.43 B | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 572.04 | -1.12 % | $ 46 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 74.38 | -1.79 % | $ 5.02 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 463.54 | 1.45 % | $ 13.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.67 | 0.11 % | $ 432 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.35 | -0.91 % | $ 388 M | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.39 | -0.36 % | $ 417 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Precipio
PRPO
|
10.9 M | $ 27.01 | 0.3 % | $ 35.1 M | ||
|
Personalis
PSNL
|
229 M | $ 7.71 | 1.31 % | $ 457 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
RadNet
RDNT
|
7.26 B | $ 59.66 | -3.37 % | $ 4.49 B | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 159.73 | 1.09 % | $ 7.92 B | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 165.68 | -0.77 % | $ 28.5 B | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 13.83 | -0.36 % | $ 3.93 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 31.01 | -2.24 % | $ 1.58 B | ||
|
Neuronetics
STIM
|
168 M | $ 1.45 | -9.69 % | $ 95.6 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.23 | -15.75 % | $ 6.7 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 263.12 | 1.94 % | $ 26 B | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
Illumina
ILMN
|
15.3 B | $ 125.57 | 1.44 % | $ 20 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 46.42 | 4.31 % | $ 2.78 B | ||
|
Celcuity
CELC
|
506 M | $ 101.62 | -4.81 % | $ 4.01 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 267.18 | 1.04 % | $ 22.2 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 3.49 | 0.29 % | $ 1.87 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.91 | -2.41 % | $ 1.01 B | ||
|
Natera
NTRA
|
5.53 B | $ 194.73 | -2.68 % | $ 19.2 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.62 | - | $ 276 M |